The controversial Gender Identity Development Service (Gids), which is run by the Tavistock and Portman NHS Foundation Trust, ...

“One of the most problematic data gaps for the Review has been trying to obtain robust data on the numbers of young people who go on to a hormone pathway at GIDS [NHS Gender Identity Service ...

The stakes of this hotly anticipated trial have only heightened since President Trump’s second term has posed an existential ...

Data obtained by the MoS reflects the massive rise in reported gender dysphoria, with 5,000 referrals to the NHS's Gender Identity Development Service for children (GIDS) in 2021/22 compared to ...

Timely documentary telling the story of the rise and fall of the Tavistock Centre's Gender Identity Development Service (GIDS), now one of the NHS's most controversial units.

However, some experts have warned that the NHS-commissioned study is “unethical ... also known as the Gender and Identity Development Service (GIDS). The 2024 Cass Review, launched after ...

Few issues in contemporary medicine have generated as much controversy as the use of puberty blockers in gender distressed children. The Government, responding to the findings of the Cass Review, has ...

A clinical trial of puberty blockers for managing children and adolescents with gender incongruence, announced in February,1 still awaits regulatory and ethical approval, amid warnings by clinicians ...

In the summer of 2022 the NHS announced it was winding up the Gender ... has spent months trying to understand what happened at GIDS. Why has it attracted such criticism and what is the best ...